Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last R$20.18 BRL
Change Today -0.40 / -1.94%
Volume 2.6M
HYPE3 On Other Exchanges
Symbol
Exchange
OTC US
Stuttgart
As of 4:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

hypermarcas sa (HYPE3) Snapshot

Open
R$20.48
Previous Close
R$20.58
Day High
R$20.56
Day Low
R$20.10
52 Week High
04/9/15 - R$21.88
52 Week Low
10/27/14 - R$15.31
Market Cap
12.8B
Average Volume 10 Days
2.5M
EPS TTM
R$0.65
Shares Outstanding
632.1M
EX-Date
05/2/13
P/E TM
30.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for HYPERMARCAS SA (HYPE3)

Related News

No related news articles were found.

hypermarcas sa (HYPE3) Related Businessweek News

No Related Businessweek News Found

hypermarcas sa (HYPE3) Details

Hypermarcas S.A., a consumer goods company, engages in the development, production, and sale of drug, health, beauty, and personal care products in Brazil. It operates in two segments, Pharma and Consumption. The company offers sweeteners under the Adocyl, Finn, and Zero-Cal names; and beauty and personal care products, including bleach and hydrogen peroxide, body deodorants, colognes, coloring, deodorants, hair line, hair styling, nail polish, shaving products, skin care, soap, and tanner/sunscreen products. It also provides child care and health products, such as absorbents, adult line, antiseptics, baby bottles, baby lines, baby powder, toothbrushes and dental products, cloth moistened, condoms, baby diapers, dental creams and gels, dental floss and tapes, diaper rash cream, disposable pads, disposable underwear, feminine hygiene products, diapers, intimate hygiene products, kids lines, lubricants, moistened towels, oral antiseptics, oral supplements, palinets, wet wipes, and cottons. In addition, the company offers pharmaceutical products, including over-the-counter medications, such as laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant drugs, and other products; prescription medications under the Farmasa, Neo Química, and Luper names; generic medications; and dermocosmetics. Hypermarcas S.A. was founded in 2001 and is headquartered in São Paulo, Brazil.

12,935 Employees
Last Reported Date: 02/6/15
Founded in 2001

hypermarcas sa (HYPE3) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hypermarcas sa (HYPE3) Key Developments

Hypermarcas S.A. Presents at 3rd Itau BBA LatAm Consumer Event, Mar-23-2015

Hypermarcas S.A. Presents at 3rd Itau BBA LatAm Consumer Event, Mar-23-2015 . Venue: London, United Kingdom.

Hypermarcas Reports Consolidated Earnings Results for the Fourth Quarter and Year Ended 2014; Provides Earnings Guidance for the Year 2015

Hypermarcas reported consolidated earnings results for the fourth quarter and year ended 2014. For the quarter, net revenue was BRL 1,301,081,000 against BRL 1,118,855,000 a year ago. Operating income before equity income and financial result was BRL 198,919,000 against BRL 261,475,000 a year ago. Net income from continuing operations was BRL 71,214,000 against BRL 58,852,000 a year ago. Adjusted EBITDA was BRL 273.2 million against BRL 252.0 million a year ago. Free cash flow was BRL 182.3 million against BRL 90.8 million a year ago. Net Income was BRL 71.5 million against BRL 54.9 million a year ago. EPS was BRL 0.11 against BRL 0.09 a year ago. Continuing Operations EBIT was BRL 198.9 million against BRL 261.5 million a year ago. EBITDA was BRL 226.7 million against BRL 289.1 million a year ago. Net Debt was BRL 3,034.3 million against BRL 2,917.4 million a year ago. Net cash provided by operating activities was BRL 131,014,000 against BRL 172,271,000 a year ago. Acquisitions of Property, Plant and Equipment were BRL 38,006 million against BRL 75,848 million a year ago. For the year, net revenue was BRL 4,680,348,000 against BRL 4,258,740,000 a year ago. Operating income before equity income and financial result was BRL 910,087,000 against BRL 896,556,000 a year ago. Net income from continuing operations was BRL 412,209,000 against BRL 258,820,000 a year ago. Adjusted EBITDA was BRL 1,106.1 million against BRL 1,002.1 million a year ago. Free cash flow was BRL 616.3 million against BRL 452.0 million a year ago. Net Income was BRL 402.7 million against BRL 256.7 million a year ago. EPS was BRL 0.64 against BRL 0.41 a year ago. Continuing Operations EBIT was BRL 910.1 million against BRL 896.6 million a year ago. EBITDA was BRL 1,019.6 million against BRL 1,001.5 million a year ago. Net cash provided by operating activities was BRL 664,001,000 against BRL 665,784,000 a year ago. Acquisitions of Property, Plant and Equipment were BRL 178,916 million against BRL 224,288 million a year ago. After analyzing the macroeconomic environment and the dynamics of the markets in which it competes, the company introduced an Adjusted EBITDA guidance around BRL 1.2 billion for the fiscal year 2015.

Hypermarcas S.A., Q4 2014 Earnings Call, Feb 09, 2015

Hypermarcas S.A., Q4 2014 Earnings Call, Feb 09, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HYPE3:BZ R$20.18 BRL -0.40

HYPE3 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GlaxoSmithKline PLC 1,576 GBp -20.50
Johnson & Johnson $99.58 USD -0.21
Pfizer Ltd/India 2,273 INR 0.00
Sanofi €95.65 EUR -1.37
View Industry Companies
 

Industry Analysis

HYPE3

Industry Average

Valuation HYPE3 Industry Range
Price/Earnings 27.6x
Price/Sales 2.4x
Price/Book 1.5x
Price/Cash Flow 27.7x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HYPERMARCAS SA, please visit www.hypermarcas.com.br. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.